Strong Time Dependence of the 76-Gene Prognostic Signature

dataset of microarray experiments from primary breast tumors used to validate the 76-gene signature (VERIDEX). No replicate, no reference sample.


Primary Purpose
-
Description of Cohorts
-
Informed Consent Given?
-
Multi-center Study?
-
Organisms
Homo sapiens
Number of subjects
-
Diseases
breast cancer
Sample Sources
-
Type of Samples Collected
-